Catalyst Wire Dossier Catalyst Wire Dossier

Botensilimab

botensilimab · Agenus Inc.
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Botensilimab, covering 2024-11-21 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma [Phase 3]

See pricing